- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
HP inks catheter deal with Guidant
Hewlett-Packard has signed an agreement with Guidant of Indianapolisgiving that cardiology device company rights to distribute coronaryand peripheral intravascular ultrasound catheters that HP haslicensed from Boston Scientific. HP executed the deal
Hewlett-Packard has signed an agreement with Guidant of Indianapolisgiving that cardiology device company rights to distribute coronaryand peripheral intravascular ultrasound catheters that HP haslicensed from Boston Scientific. HP executed the deal becauseit believes that Guidant's distribution channels are more suitedfor the IVUS market than its own, according to the Andover, MA,company.
HP gained access to the catheters through an agreement lastyear with Boston Scientific, which at the time was preparing tobuy catheter developers Cardiovascular Imaging Systems and ScimedLife Systems. To avoid a monopoly in the IVUS market, the FederalTrade Commission required Boston Scientific to enter a consentdecree in which it licensed the technology to a third party, Hewlett-Packard(SCAN 3/15/95).
HP already has a deal with Guidant for development of guideddirectional atherectomy catheters. Guidant also has rights todistribute Hewlett-Packard's Sonos Intravascular Ultrasound Systemwith the catheters.
Can MRI-Based AI Enhance Risk Stratification in Prostate Cancer?
January 13th 2025Employing baseline MRI and clinical data, an emerging deep learning model was 32 percent more likely to predict the progression of low-risk prostate cancer (PCa) to clinically significant prostate cancer (csPCa), according to new research.
Shaping the Future of Radiology in 2025: Trends, Threats, and Opportunities
January 10th 2025How do we respond to challenges with staff recruitment, cybersecurity, and looming hospital takeovers in radiology? This author assesses key trends in radiology and offers key insights to stay competitive in the field.
Can MRI Have an Impact with Fertility-Sparing Treatments for Endometrial and Cervical Cancers?
January 9th 2025In a literature review that includes insights from recently issued guidelines from multiple European medical societies, researchers discuss the role of magnetic resonance imaging (MRI) in facilitating appropriate patient selection for fertility-sparing treatments to address early-stage endometrial and cervical cancer.
